KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Xenon Pharmaceuticals (XENE) Gross Profit: 2012-2022

Historic Gross Profit for Xenon Pharmaceuticals (XENE) over the last 11 years, with Dec 2022 value amounting to $9.4 million.

  • Xenon Pharmaceuticals' Gross Profit was N/A to $7.5 million in Q1 2025 from the same period last year, while for Mar 2025 it was $16.9 million, marking a year-over-year change of. This contributed to the annual value of $9.4 million for FY2022, which is 48.83% down from last year.
  • Xenon Pharmaceuticals' Gross Profit amounted to $9.4 million in FY2022, which was down 48.83% from $18.4 million recorded in FY2021.
  • Xenon Pharmaceuticals' 5-year Gross Profit high stood at $32.2 million for FY2020, and its period low was -$1.4 million during FY2018.
  • Over the past 3 years, Xenon Pharmaceuticals' median Gross Profit value was $18.4 million (recorded in 2021), while the average stood at $20.0 million.
  • Per our database at Business Quant, Xenon Pharmaceuticals' Gross Profit tumbled by 548.23% in 2018 and then surged by 589.89% in 2019.
  • Yearly analysis of 5 years shows Xenon Pharmaceuticals' Gross Profit stood at -$1.4 million in 2018, then soared by 589.89% to $6.8 million in 2019, then surged by 371.02% to $32.2 million in 2020, then crashed by 42.68% to $18.4 million in 2021, then slumped by 48.83% to $9.4 million in 2022.